JTB SRATEGIES

Lobbying for MANAX RUTSON CLINICAL DEVELOPMENT LLC · Healthcare Private Equity

Filing Registration - Amendment

2nd Quarter (Apr 1 - June 30) 2025 · New York · posted Jul 16, 2025

Lobbying activity 2

Health Issues

Rare disease drug development reciprocity.

Financial Institutions/Investments/Securities

Rare disease drug development reciprocity.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.